Open AccessAngiotensin II: tapping the cell cycle machinery to kill endothelial cells
Author(s) -
Michael A. O’Reilly
Publication year - 2012
Publication title -
ajp lung cellular and molecular physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.892
H-Index - 163
eISSN - 1522-1504
pISSN - 1040-0605
DOI - 10.1152/ajplung.00260.2012
Subject(s) - medicine , lung , idiopathic pulmonary fibrosis , parenchyma , fibrosis , pathology , hyperplasia , inflammation , immunology
idiopathic pulmonary fibrosis (IPF) is an insidious and progressive disease that has devastating consequences on affected individuals and their families ([4][1], [22][2]). Approximately 50,000 individuals in the United States have this disease and most will develop respiratory failure within 3 to 5
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom